A Composite Endpoint for Treatment Benefit According to Patient Preference.

Lu, Ying; Zhao, Qian; Zou, Jiying; Yan, Shiyan; Tamaresis, John S; Nelson, Lorene; Tu, Xin M; Chen, Jie; Tian, Lu

Lu, Ying; Zhao, Qian; Zou, Jiying; Yan, Shiyan; Tamaresis, John S; Nelson, Lorene; Tu, Xin M; Chen, Jie; Tian, Lu.

Afiliação

Lu Y; Department of Biomedical Data Science, Stanford University School of Medicine.
Zhao Q; Department of Epidemiology and Population Health, Stanford University School of Medicine.
Zou J; Department of Biomedical Data Science, Stanford University School of Medicine.
Yan S; Department of Biostatistics, Guangzhou Medical University.
Tamaresis JS; Department of Statistics, Stanford University.
Nelson L; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences.
Tu XM; Department of Biomedical Data Science, Stanford University School of Medicine.
Chen J; Department of Epidemiology and Population Health, Stanford University School of Medicine.
Tian L; Department of Family Medicine and Health Sciences, University of California, San Diego.

Stat Biopharm Res ; 14(4): 408-422, 2022.

Article em En | MEDLINE | ID: mdl-37981982

Palavras-chave

Desirability of Outcome Ranking (DOOR); Wilcoxon-Mann-Whitney U-statistic; clinical trials; multivariate endpoints; patient reported outcomes; patient-centered approach

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article